|
Hi Chrisy,
Thanks much for the info...and some rebuttal ammo. Re. any Her2 targeted therapy at present, our doc is thinking we've burned through Herceptin and Tykerb, at least for now. Herceptin was in the regimen for a year, then Tykerb another year. Each did the trick for awhile, but then some progression. I do wonder about any adjuvant advantage---keeping the cancer from any new fronts, with the Her2 therapies.
Thanks!
Barry
|